Industry Partners
CellReGen™ has or has had relationships with the following industry companies in support of their clinical trials at bedside or through process development, manufacturing and scale up of novel cellular and non-cellular products used for therapies and immunotherapies in human clinical trials. These projects involved either cGMP or non-cGMP (or in some cases both) development and manufacturing.
- Abu Dhabi Stem Cells Center (ADSCC)
- Alucent Biomedical
- Amsterdam University
- Athersys
- BioLineRx, Ltd.
- California Institute for Regenerative Medicine
- Celgene Corporation
- Children’s Oncology Group
- CRISPR Therapeutics, AG
- Discgenics
- Eliksa Therapeutics
- Elute, Inc.
- Exorphia
- EyeGate Pharmaceuticals
- GlaxoSmithKline
- Immunotherapy (CETI)
- Iovance Biotherapeutics
- iVeena
- Janssen Research & Development
- Kiora Pharmaceuticals, Inc.
- Kite Pharma, Inc.
- LDS Hospital
- Longeveron
- National Institute of Health
- Neon Therapeutics, Inc.
- Neurona
- Novartis
- Ocucell Inc.
- Orca Bio, Inc.
- Peytant Solutions, Inc.
- Pharmicell, Ltd.
- Primary Children’s Hospital
- Program for Cell Enhancement and Technologies for Immunotherapy (CETI)
- Q-Therapeutics
- Reprocell
- Rutgers University
- SymbioCellTech
- Thunder Biotech, Inc.